11월 19일 기준, 노바백스의 긴급사용승인 신청과 승인 현황을 표로 정리하였습니다.
[Summary]
위의 표에 대한 근거는 아래의 링크로 확인하시면 됩니다.
[신청/승인 관련 기사 정리 - 시간 순]
- 21.08.05 : 노바백스, 인도, 인도네시아, 필리핀에 긴급사용승인 신청서 제출
Novavax and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines for Emergency U
- Novavax and Serum Institute of India file regulatory submissions to the Drugs Controller General of India and to regulatory agencies in Indonesia and Philippines for Novavax' recombinant...
ir.novavax.com
- 21.09.23 : 노바백스, WHO 승인 신청
Novavax and Serum Institute of India Announce Submission to World Health Organization for Emergency Use Listing of Novavax' COVI
Novavax and Serum Institute of India file regulatory submission for World Health Organization Emergency Use Listing of Novavax' recombinant nanoparticle protein-based COVID-19 vaccine...
ir.novavax.com
- 21.10.27 : 노바백스, 영국 승인 신청
Novavax Files for Authorization of its COVID-19 Vaccine in the United Kingdom
Filing marks first protein-based COVID-19 vaccine submitted to MHRA for authorization All modules required for regulatory review, including CMC data, are now complete Submission based on Phase 3...
ir.novavax.com
- 21.10.29 : 노바백스, 호주 승인 신청
Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the completion of its...
ir.novavax.com
- 21.11.01 : 노바백스, 캐나다, 유럽연합 승인 신청
Novavax Files for COVID-19 Vaccine Authorization with Health Canada and Completes Submission for Rolling Review to European Medi
Health Canada filing marks first protein-based COVID-19 vaccine submitted for authorization to regulatory authorities in Canada Submission of all modules required for regulatory review, including...
ir.novavax.com
- 21.11.01 : 노바백스, 인도네시아에서 긴급승인 완료
Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in Indonesia
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd....
ir.novavax.com
- 21.11.03 : 노바백스, 뉴질랜드 승인 신청
Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand
- Submission to New Zealand's Medsafe marks the first protein-based COVID-19 vaccine submitted for authorization to regulatory authorities in New Zealand - All modules required for regulatory...
ir.novavax.com
- 21.11.15 : 노바백스, 한국 승인 신청
https://www.news1.kr/articles/?4493906
노바백스 품목허가 신청…선계약 2000만명분 '물꼬' 트이나(종합)
사실 앞에 겸손한 민영 종합 뉴스통신사 뉴스1
www.news1.kr
- 21.11.17 : 노바백스 필리핀에서 긴급사용승인 완료
Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in the Philippines
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd....
ir.novavax.com
'주식 > NEWS & ISSUES' 카테고리의 다른 글
| 노바백스 유럽승인 진행현황 (0) | 2021.11.18 |
|---|---|
| 대한항공 - 아시아나 기업결합심사 신청/승인현황 (2) | 2021.11.17 |
| Novavax(NVAX) Current Approval Status (0) | 2021.11.16 |
| 노바백스 주요 뉴스 정리 (0) | 2021.11.04 |
| 항공사 합병 뉴스 요약 (0) | 2021.10.28 |